P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. [electronic resource]
Producer: 19980127Description: 435-49 p. digitalISSN:- 1042-8194
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- pharmacology
- Chlorambucil -- pharmacology
- Drug Resistance, Neoplasm
- Drug Screening Assays, Antitumor
- Female
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Nuclear Proteins
- Polymorphism, Single-Stranded Conformational
- Prognosis
- Proto-Oncogene Proteins -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Proto-Oncogene Proteins c-mdm2
- RNA, Messenger -- metabolism
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- metabolism
- Vidarabine -- analogs & derivatives
- bcl-2-Associated X Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.